Literature DB >> 9856984

Assembly of the sarcoglycan complex. Insights for muscular dystrophy.

K H Holt1, K P Campbell.   

Abstract

Four unique transmembrane glycoproteins comprise the sarcoglycan complex in striated muscle. The sarcoglycan complex contributes to maintenance of sarcolemma integrity. A shared feature of four types of autosomal recessive limb girdle muscular dystrophy (LGMD) is that mutations in a single sarcoglycan gene result in the loss of all sarcoglycans at the sarcolemma. The mechanism of destabilization is unknown. We report here our findings of sarcoglycan complex biosynthesis in a heterologous cell system. We demonstrate that the sarcoglycans are glycosylated and assemble into a complex that resides in the plasma membrane. Complex assembly was dependent on the simultaneous synthesis of all four sarcoglycans. Mutant sarcoglycans block complex formation and insertion of the sarcoglycans into the plasma membrane. This constitutes the first biochemical evidence to support the idea that the molecular defect in sarcoglycan-deficient LGMD is because of aberrant sarcoglycan complex assembly and trafficking, which leads to the absence of the complex from the sarcolemma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856984     DOI: 10.1074/jbc.273.52.34667

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle.

Authors:  L Féasson; D Stockholm; D Freyssenet; I Richard; S Duguez; J S Beckmann; C Denis
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

2.  Structural and functional analysis of the sarcoglycan-sarcospan subcomplex.

Authors:  Gaynor Miller; Emily L Wang; Karin L Nassar; Angela K Peter; Rachelle H Crosbie
Journal:  Exp Cell Res       Date:  2006-12-14       Impact factor: 3.905

Review 3.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

4.  Biglycan is an extracellular MuSK binding protein important for synapse stability.

Authors:  Alison R Amenta; Hilliary E Creely; Mary Lynn T Mercado; Hiroki Hagiwara; Beth A McKechnie; Beatrice E Lechner; Susana G Rossi; Qiang Wang; Rick T Owens; Emilio Marrero; Lin Mei; Werner Hoch; Marian F Young; David J McQuillan; Richard L Rotundo; Justin R Fallon
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

5.  Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development.

Authors:  Michael S Rafii; Hiroki Hagiwara; Mary Lynn Mercado; Neung S Seo; Tianshun Xu; Tracey Dugan; Rick T Owens; Magnus Hook; David J McQuillan; Marian F Young; Justin R Fallon
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

6.  Restoration of gamma-sarcoglycan localization and mechanical signal transduction are independent in murine skeletal muscle.

Authors:  Elisabeth R Barton
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

7.  Dilated cardiomyopathy mutations in δ-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability.

Authors:  Matthew D Campbell; Marc Witcher; Anoop Gopal; Daniel E Michele
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-03-11       Impact factor: 4.733

8.  Sarcospan-deficient mice maintain normal muscle function.

Authors:  C S Lebakken; D P Venzke; R F Hrstka; C M Consolino; J A Faulkner; R A Williamson; K P Campbell
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 9.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

10.  Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.

Authors:  Stefano Gastaldello; Simona D'Angelo; Susanna Franzoso; Marina Fanin; Corrado Angelini; Romeo Betto; Dorianna Sandonà
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.